Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPURE.L Regulatory News (PURE)

  • There is currently no data for PURE

Trading Statement

6 Jan 2016 07:00

RNS Number : 9404K
PureCircle Limited
06 January 2016
 

 

 

 

PURECIRCLE LIMITED

TRADING UPDATE

PureCircle (LSE: PURE), the world's leading producer and marketer of high purity stevia ingredients, today provides a trading update in respect of the six month period from 1 July 2015 to 31 December 2015, being the first half of its Financial Year 2016 (1H FY16). The Company's interim results for 1H FY16 will be announced on Monday 29 February 2016.

Sales

Sales in 1H FY16 are expected to be not less than US$54m, an increase of 25% against 1H FY15 (US$43m).

There has been growth in sales across all global sales regions and across all ingredients as our innovation continues to unlock new Food and Beverage adoption of stevia and support continued roll-outs of products already launched.

Margins, EBITDA and net result

The Group expects gross margin, EBITDA and net result all to increase significantly compared to 1H FY15.

Group gross margin is expected to be not less than US$22m, an increase of 52% against 1H FY15 (US$14m). The improvement in gross margin principally reflects higher sales volumes, increasing contributions from our expanding portfolio of innovative new products and more stable leaf supply.

 

EBITDA is expected to be not less than US$13m, an increase of US$7m (105%) against 1H FY15 (US$6m), reflecting the benefit of higher sales volumes and improving margins.

Other expenses: In 1H the Group moved to the Main Market of the London Stock Exchange and incurred costs of US$2m doing so, which will be charged to profit in 1H FY16. In addition in 1H FY16 the Group has incurred Long Term Incentive Plan and related costs of US$4m (1H FY15 $3m).

Foreign exchange: In 1H the Malaysian Ringgit has devalued by more than 20% against the US$ giving rise to a foreign exchange gain of US$3m.

The Group's net result for 1H FY16 is expected to be a net profit of approximately US$5m, an improvement of almost US$6m against 1H FY15 (loss of US$0.9m). A net profit of US$5m would represent Earnings Per Share of US$0.03 per share.

Cash, net debt and funding headroom

The Group ended 1H FY16 with net debt of US$ 46m (1H FY15 US$52m) and cash and facility headroom of US$73m (1H FY15 US$76m). The Group is sufficiently funded for its current expansion plans.

Commenting on the 1H FY16 trading update, the Group CEO Magomet Malsagov said: 1H FY16 has seen continued market growth across all Food and Beverage categories and all geographical regions enabled by our stevia innovation. In July we launched Sigma D and Sigma T, the first products in our Matrix Solutions range that provide category specific taste solutions. Then in December we launched our Zeta TM suite of ingredients that enable great tasting product formulations with deeper calorie reductions.

In November India finally approved the use of stevia which opens up the market to a further 1.3 billion consumers.

Latest Mintel data shows there are now more than 9,000 products in market using stevia, more than 70% of which have been launched within the last three years.

Global obesity continues to worsen with more than 600 million people now predicted to be obese by 2035 (up 50% from 400 million in 2013). Public debate and calls for regulatory action to address the issue are increasing, particularly concerning added sugar. At the same time, consumers are actively seeking natural sustainable sources for their sweeteners, as opposed to using artificial low calorie products.

These developments give further support to our long held assessment that stevia has the potential to become a mass volume mainstream ingredient in Food and Beverage products and for PureCircle to continue to play a leadership role in the development of that market. With continued sales growth we would expect further improvements in profitability.

 

6 January 2016

 

Enquiries:

PureCircle Limited (www.purecircle.com)

Magomet Malsagov, CEO

+603 2166 2066

William Mitchell, CFO

+44 7974 005 163

 

NOTES TO EDITORS

PureCircle is the world's leading producer of high-purity stevia ingredients for the global food and beverage industry. Its mission is to encourage healthier diets around the world through the supply of natural ingredients to the global food and beverage industry. Its vision is to lead the global expansion of stevia as the next mass volume, natural-origin sweetener. PureCircle has offices around the world with the global headquarters in Kuala Lumpur, Malaysia. The Business was founded in 2002. PureCircle's shares are listed on the main market of the London Stock Exchange and trade under the ticker symbol PURE. For more information, visit: www.purecircle.com.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTXELLBQFFBBBX
Date   Source Headline
29th Oct 20097:00 amRNSProduct Launch
27th Oct 200912:35 pmRNSHolding(s) in Company
21st Oct 20097:00 amRNSPureCircle and PepsiCo to receive Scientific Excel
20th Oct 20097:00 amRNSProduct Launch
15th Oct 200910:00 amRNSTrading Statement
8th Oct 20097:00 amRNSDirector Declaration
23rd Sep 20097:00 amRNSFinal Results
8th Sep 20098:32 amRNSStatement re Approval
4th Sep 20093:00 pmRNSStatement re Shareholding
2nd Sep 200910:10 amRNSChange of Adviser
8th Jul 20097:00 amRNSTrading Update
15th Jun 20098:41 amRNSNotification of a Major Interest
27th Apr 20097:02 amRNSCompletion of Extract Plant Complex
1st Apr 20097:00 amRNSDealings in Shares
5th Mar 20099:20 amRNSDirector's Dealing
4th Mar 20097:00 amRNSHalf Yearly Report
29th Jan 20097:00 amRNSSENIOR INTERNATIONAL SALES TEAM APPOINTMENT
19th Jan 20097:00 amRNSAppointment
13th Jan 20097:00 amRNSAppointment of Head of PureCircle USA
12th Jan 20097:09 amRNSNotice of Results
6th Jan 20097:00 amRNSStrategic Global Collaboration
5th Jan 20097:00 amRNSDirector Dealings
18th Dec 20087:00 amRNSRegulatory Approval
24th Nov 20087:51 amRNSExecutive Management Appointments
10th Nov 20087:55 amRNSIssuance of Options
7th Nov 20089:51 amRNSExercise of Options
17th Oct 20083:05 pmRNSDealings in shares
15th Oct 20087:00 amRNSFinal Results
13th Oct 200812:58 pmRNSBoard Change
10th Oct 20089:44 amRNSApproval Announced
22nd Aug 20087:00 amRNSRevised Results Day
20th Aug 20088:42 amRNSBoard Appointment
31st Jul 20083:42 pmRNSMajor contract win
21st Jul 20088:45 amRNSNotice of Interim Results
2nd Jul 20088:10 amRNSRe Share Holdings
2nd Jul 20087:03 amRNSDirector's Dealings
1st Jul 20081:08 pmRNSStrategic Partnership
16th Jun 20088:34 amRNSLong Term Incentive Plan
2nd Jun 20089:27 amRNSAGM and Board appointments
2nd Jun 20087:00 amRNSDealings in Shares
20th May 20089:08 amRNSCompletion of aquisition and
9th May 20088:39 amRNSNotice of AGM
7th May 20087:00 amRNSAppointment
6th May 20088:33 amRNSKenya Joint Venture
22nd Apr 200811:19 amRNSInvestor Presentation
7th Apr 20088:37 amRNSAcquisition
1st Apr 20087:01 amRNSFinal Results
31st Mar 20089:19 amRNSNotification re: results
10th Mar 20081:16 pmRNSResults Date
28th Feb 20088:43 amPRNHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.